Edexcel GCSE Biology (1BI0) — Health, Disease and Medicines
How does a doctor find a microscopic cancer cluster or a hidden blood clot without performing invasive surgery? They use monoclonal antibodies (mAbs), which act like microscopic homing missiles designed to track down specific targets inside the body. These lab-made proteins are identical copies of one type of antibody, engineered to bind to exactly one specific antigen.
To create these targeted antibodies, scientists first inject a mouse with the target antigen, such as a cancer marker or clot protein. The mouse's immune system responds by producing white blood cells called B-lymphocytes that create the specific antibody needed. However, these lymphocytes do not divide easily outside the body.
To solve this, scientists extract the B-lymphocytes and fuse them with myeloma cells, which are fast-dividing cancer cells that do not produce antibodies themselves. This fusion creates a unique hybrid cell called a hybridoma. The hybridoma cells are then cloned to produce virtually limitless quantities of identical, highly specific monoclonal antibodies.
For monoclonal antibodies to be useful in diagnosis, scientists must attach a "tag" to them before they enter the patient. They are chemically bonded to radioactive isotopes (like Technetium-99m) or fluorescent dyes that glow under UV light. Once labelled, they are injected into the patient's bloodstream.
Because the binding sites on the antibodies are perfectly complementary in shape to the target antigen, they exhibit specific binding. This means they exclusively attach to the target disease site and do not bind to healthy cells, avoiding unnecessary interactions. The labelled antibodies accumulate in high concentrations wherever the disease is located.
When searching for cancer, the antibodies are designed to target tumour markers, which are unique antigens found on the cell surface membrane of cancer cells but essentially absent on healthy cells.
Alternatively, if doctors suspect a deep vein thrombosis, they need to locate a blood clot. The target antigen here is fibrin, which is the insoluble protein that forms a mesh to trap blood cells during clotting.
After allowing time for the unattached antibodies to clear the bloodstream, medical professionals use specialised equipment to look inside the patient. For radioactive tracers, they use PET scanners or gamma cameras to detect the emitted radiation.
Because the radioactive markers have accumulated at the site of the complementary antigens, the scanner detects a concentrated burst of gamma radiation. This appears on the doctor's screen as a brightly lit area known as a "hot spot," allowing for precise diagnosis and targeted treatment.
Students often state that monoclonal antibodies destroy the cancer cells or blood clots during diagnosis, but actually they only locate them because their primary diagnostic role is to carry a radioactive or fluorescent marker.
In 'Explain' questions about how monoclonal antibodies diagnose conditions, examiners expect you to link three points: the specific binding of complementary shapes, the attachment of a radioactive marker, and the use of a scanner to visualize the location.
When discussing the diagnosis of blood clots, you must explicitly name fibrin as the target protein to secure full marks on the Edexcel mark scheme.
Always use the scientific term 'complementary' rather than 'matching' or 'same shape' when describing how the antibody's binding site fits the specific antigen.
Monoclonal antibodies (mAbs)
Identical copies of a specific type of antibody produced from a single clone of hybridoma cells.
B-lymphocytes
A type of white blood cell, typically extracted from the spleen of an immunized mouse, that produces specific antibodies.
Myeloma
A type of fast-dividing cancer cell used in laboratories to fuse with antibody-producing cells.
Hybridoma
A hybrid cell formed by fusing an antibody-producing B-lymphocyte with a fast-dividing myeloma cell.
Radioactive isotopes
Atoms that emit radiation, commonly used as tracers attached to antibodies for internal medical imaging.
Fluorescent dyes
Chemical markers that glow brightly under UV light, attached to antibodies to highlight target cells in lab samples.
Complementary
Describes the precisely matching shapes of an antibody's binding site and its target antigen, similar to a lock and key.
Specific binding
The process where an antibody exclusively attaches to one target antigen due to their perfectly matching complementary shapes.
Tumour markers
Unique antigens present on the cell surface membrane of cancer cells that are largely absent from healthy cells.
Fibrin
The insoluble protein that forms a mesh during the blood-clotting process, acting as a target for clot-locating antibodies.
PET scanners
Specialized medical imaging machines that detect radiation in 3D to visualize the location of radioactively labelled antibodies.
Gamma cameras
Medical detection devices used to scan a patient's body and identify concentrated areas of gamma radiation.
Put your knowledge into practice — try past paper questions for Biology
Monoclonal antibodies (mAbs)
Identical copies of a specific type of antibody produced from a single clone of hybridoma cells.
B-lymphocytes
A type of white blood cell, typically extracted from the spleen of an immunized mouse, that produces specific antibodies.
Myeloma
A type of fast-dividing cancer cell used in laboratories to fuse with antibody-producing cells.
Hybridoma
A hybrid cell formed by fusing an antibody-producing B-lymphocyte with a fast-dividing myeloma cell.
Radioactive isotopes
Atoms that emit radiation, commonly used as tracers attached to antibodies for internal medical imaging.
Fluorescent dyes
Chemical markers that glow brightly under UV light, attached to antibodies to highlight target cells in lab samples.
Complementary
Describes the precisely matching shapes of an antibody's binding site and its target antigen, similar to a lock and key.
Specific binding
The process where an antibody exclusively attaches to one target antigen due to their perfectly matching complementary shapes.
Tumour markers
Unique antigens present on the cell surface membrane of cancer cells that are largely absent from healthy cells.
Fibrin
The insoluble protein that forms a mesh during the blood-clotting process, acting as a target for clot-locating antibodies.
PET scanners
Specialized medical imaging machines that detect radiation in 3D to visualize the location of radioactively labelled antibodies.
Gamma cameras
Medical detection devices used to scan a patient's body and identify concentrated areas of gamma radiation.
